SCHEMBL8129477

SCHEMBL8129477

CCCCCC(CC(=O)Nc1cc(C(=O)O)ccc1C(C)(C)C)c1ccc(C(=O)CC)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 3/20 0.38
LTB4R Q15722 2/20 0.38
EPHX2 P34913 1/20 0.38
RARA P10276 1/20 0.36
RARB P10826 1/20 0.36
RARG P13631 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PLA2G4B P0C869 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 2/20 0.35
MAPK1 P28482 1/20 0.35
AHR P35869 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8134962 0.94 THRA (0.38) NR1H4LTB4REPHX2RARARARB
SCHEMBL8121040 0.93 ERAP2 (0.39) TSHRMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL8130312 0.92 KMT2A (0.39) NR1H4MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL8134186 0.92 NR1H4 (0.39) NR1H4LTB4REPHX2RARARARB
SCHEMBL8128937 0.91 KMT2A (0.40) NR1H4LTB4REPHX2RARARARB
SCHEMBL8142168 0.91 NR1H4 (0.41) NR1H4LTB4REPHX2RARARARB
SCHEMBL8128488 0.91 NR1H4 (0.38) NR1H4LTB4REPHX2RARARARB
SCHEMBL8128319 0.90 LPAR1 (0.42) NR1H4LTB4REPHX2RARARARB
SCHEMBL8129465 0.90 L3MBTL1 (0.42) NR1H4LTB4REPHX2RARARARB
SCHEMBL8127972 0.90 LPAR1 (0.41) RARARARBRARGTSHRPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed